Supporting the Pharmaceutical Industry With 21 CFR Part 11 Compliance Readiness
White Paper Sep 16, 2019
This document describes how Malvern Panalytical systems support system owners, meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.
Related White Papers
Identifying biomarkers that predict which patient populations are most likely to respond to a particular treatment can increase the chances of a new investigational drug ultimately entering the market. In this whitepaper, you will discover how advanced bioinformatics can help you overcome biomarker discovery challenges.READ MORE